[
    [
        {
            "time": "",
            "original_text": "平安证券----生物医药行业周报：《政府工作报告》发布，将进一步深化医药卫生体制改革【行业研究】",
            "features": {
                "keywords": [
                    "政府工作报告",
                    "医药卫生体制改革",
                    "生物医药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "平安证券----生物医药行业周报：《政府工作报告》发布，将进一步深化医药卫生体制改革【行业研究】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股普遍调整，健帆生物、凯莱英、广联达、国瓷材料、泰格医药领跌",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "健帆生物",
                    "凯莱英",
                    "广联达",
                    "国瓷材料",
                    "泰格医药"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍调整，健帆生物、凯莱英、广联达、国瓷材料、泰格医药领跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医疗健康行业：调整是布局良机 重点关注新冠疫苗加速接种带来的投资机会",
            "features": {
                "keywords": [
                    "医疗健康",
                    "新冠疫苗",
                    "接种",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗健康行业：调整是布局良机 重点关注新冠疫苗加速接种带来的投资机会",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[银河医药孟令伟/刘晖】行业深度丨小核酸时代终将到来，优质赛道如何掘金？",
            "features": {
                "keywords": [
                    "银河医药",
                    "小核酸时代",
                    "优质赛道",
                    "掘金"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[银河医药孟令伟/刘晖】行业深度丨小核酸时代终将到来，优质赛道如何掘金？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业报告：创新药企商业化能力的再思考",
            "features": {
                "keywords": [
                    "医药生物",
                    "创新药企",
                    "商业化能力"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业报告：创新药企商业化能力的再思考",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]